RISS is pleased to announce its 'Call for Applications' for the final round of its TGA Licence Maintenance program. Through this program GMP cell therapy facilities may attract funding of up to $50,000 to subsidise the costs associated with maintaining their TGA licence.

Facilities are eligible for consideration if they 1) hold a TGA licence in the field of human cells for transplant, 2) agree to make their facility accessible to external researchers and 3) agree to provide an equal co-investment (cash or in-kind). Details of the program are described in our Access_and_Pricing_Code.doc. To be considerded applicants must complete an RISS_Application_Form.doc and submit it to stewart.hay@rissltd.com.by the 19th of December 2010.

This Call for Applications is limited to this grant program and does not include our Researcher Access program.

If you have any questions regarding this grant program please call Stewart Hay on 0428 65 82 82.